Nathan Scott
Impact in
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Glycosylation and Glycoproteins Research 2
-
- Herpesvirus Infections and Treatments 3
- Cytomegalovirus and herpesvirus research 2
- Co-authors
- Lioudmila Tchistiakova (1 shared paper)Michael Ritchie (1 shared paper)Graham Robertson (2 shared papers)Christopher W. Bell (2 shared papers)J. Millar Whalley (1 shared paper)G. Hudson (1 shared paper)Valentyn Mohylyuk (4 shared papers)Fang Liu (3 shared papers)
- Journals
- Journal of Pharmaceutical Sciences (2 papers)SAE technical papers on CD-ROM/SAE technical paper series (2 papers)AAPS PharmSciTech (1 paper)International Journal of Pharmaceutics (1 paper)BMC Biotechnology (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Nathan Scott
17 papers receiving 650 citations
Peers
Comparison fields: 5 of 87
- Oncology 223
- Radiology, Nuclear Medicine and Imaging 178
- Epidemiology 219
- Pharmaceutical Science 37
- Endocrinology, Diabetes and Metabolism 93
Countries citing papers authored by Nathan Scott
This map shows the geographic impact of Nathan Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Scott more than expected).
Fields of papers citing papers by Nathan Scott
This network shows the impact of papers produced by Nathan Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Scott. The network helps show where Nathan Scott may publish in the future.
Co-authors
The 25 scholars most cited alongside Nathan Scott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 235 | |
| 2 | 2014 | 140 | |
| 3 | 1989 | 75 | |
| 4 | 2012 | 53 | |
| 5 | 1991 | 35 | |
| 6 | 2020 | 23 | |
| 7 | 2019 | 18 | |
| 8 | 2010 | 16 | |
| 9 | 2020 | 16 | |
| 10 | 2008 | 15 | |
| 11 | 2021 | 14 | |
| 12 | 2018 | 12 | |
| 13 | 2021 | 9 | |
| 14 | 2020 | 7 | |
| 15 | 1988 | 4 | |
| 16 | 2024 | 2 | |
| 17 | 1964 | 1 |
About Nathan Scott
Nathan Scott is a scholar working on Molecular Biology, Epidemiology, Immunology, Health, Toxicology and Mutagenesis and Oncology, having authored 17 papers that have together received 675 indexed citations. Recurring topics across this work include Air Quality and Health Impacts (3 papers), Herpesvirus Infections and Treatments (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Drug Solubulity and Delivery Systems (2 papers), Vehicle emissions and performance (2 papers), Glycosylation and Glycoproteins Research (2 papers), Cytomegalovirus and herpesvirus research (2 papers) and T-cell and Retrovirus Studies (2 papers). The work is most often cited by research in Oncology (223 citations), Radiology, Nuclear Medicine and Imaging (178 citations), Epidemiology (219 citations), Pharmaceutical Science (37 citations) and Endocrinology, Diabetes and Metabolism (93 citations). Nathan Scott has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Lioudmila Tchistiakova, Michael Ritchie, Graham Robertson, Christopher W. Bell, J. Millar Whalley, G. Hudson, Valentyn Mohylyuk, Fang Liu, Kavil Patel and Martha J. Kelly. Their work appears in journals such as Journal of Pharmaceutical Sciences, SAE technical papers on CD-ROM/SAE technical paper series, AAPS PharmSciTech, International Journal of Pharmaceutics and BMC Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.